Drug intelligence / Profile preview

peptide 1018

Development stage
Unknown
Lead developer
University of British Columbia
Modality
Peptides
Administration
Topical
01

Overview

Peptide 1018, also known as IDR-1018, is a synthetic 12-amino acid cationic antimicrobial peptide (AMP) and innate defense regulator derived from bovine bactenecin (Bac2A). It is specifically designed to target and disrupt bacterial biofilms, which are often resistant to conventional antibiotics. The peptide works by binding to and triggering the degradation of the stress-response signaling molecules guanosine tetraphosphate and guanosine pentaphosphate ((p)ppGpp), which are essential for biofilm development and maintenance in both Gram-positive and Gram-negative bacteria. Additionally, peptide 1018 acts as an immunomodulator, enhancing protective innate immune responses while suppressing potentially harmful inflammatory signals. It is being investigated for its potential to treat oral biofilms associated with dental caries and periodontitis, as well as for applications in wound healing and treating multi-drug resistant infections.

Other names
Innate Defense Regulator peptide 1018IDR peptide 1018VRLIVAVRIWRR-NH2VRLIVAVRIWRR-NH-2VRLIVAVRIWRR-NH 2
02

Targets

ppGpp (Guanosine pentaphosphate)

Beyond the preview

Go deeper on peptide 1018.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on peptide 1018.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call